ABOUT INVIDA
INSPIRING INNOVATION. INVIGORATING LIVES.

INVIDA is one of Asia Pacific’s leading specialty pharmaceutical companies, focusing on commercialisation services [see PharmaLink] and proprietary products [see Inovail]. INVIDA covers Asia Pacific through its 13 subsidiaries and has more than 3,700 employees in marketing and sales.

Specialisation occurs within the commercialisation process and total focus on operational excellence and by focusing on selected therapeutic areas in the proprietary business – Dermatology, Female Health and Complementary Oncology [see Inovail].

INVIDA’s pan-Asia Pacific marketing organisation and its capacity for product registration and development make the company and its subsidiaries an attractive partner for pharmaceutical outlicensers.

Inovail Holdings Pte Ltd is a newly-formed specialty pharmaceutical company focusing on market-driven innovation in the Asia Pacific Region.

Our areas of specialty are in primary care, dermatology and female healthcare. Within these areas, Inovail’s experienced teams are able to integrate capabilities ranging from market feasibility studies, regulatory affairs, marketing management, medical affairs. Our growth strategy is focused on driving innovation in the Asia Pacific Region.

Our activities range from in-licensing of innovative compounds to acquisition of existing brands. Inovail sees itself as a partner for the R&D based pharmaceutical industry that supports the refocusing of companies on their core businesses by assuming full responsibilities for various business areas, either by acquisition or in-licensing. Companies with investments in dermatology, complementary oncology and female healthcare will find value in our strategic partnership.

With the breadth of our services and the depth of our regional knowledge, we are the ideal strategic partner to bring your products to prominence in Asia Pacific.